Tag: #RisdiON

One of the most persistent challenges in gene and cell therapy is not simply delivering a therapeutic gene to the right cell — it is ensuring that, once delivered, the gene’s expression can be turned on and off with sufficient precision to remain both safe and effective over time. Current inducible systems, which allow researchers…